CCL2 is associated with immune tolerance and recruitment of suppressive immune cells such as myeloid derived suppressor cells (MDSC) and regulatory T cells (Tregs) in cancer [23,24,25]; these cells are also implicated in graft survival [26]. Here, CCL2 is linked to cancer.